Asuragen Inc (Asuragen), a subsidiary of Bio-Techne Corp, is an oncology molecular diagnostic company that offers laboratory medicine solutions. The company's products include amplidex, quantidex and custom reagents among others. It provides custom and companion diagnostic services that include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents in vitro transcribed RNA and plasmid DNA kits. The company distributes its products across Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US. Asuragen is headquartered in Austin, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Asuragen Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Asuragen Inc Company Overview
- Asuragen Inc Company Snapshot
- Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
- Asuragen Inc - Pipeline Analysis Overview
- Asuragen Inc - Key Facts
- Asuragen Inc - Major Products and Services
- Asuragen Inc Pipeline Products by Development Stage
- Asuragen Inc Pipeline Products Overview
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy Product Overview
- Companion Diagnostic Test - Huntington's Disease
- Companion Diagnostic Test - Huntington's Disease Product Overview
- Immunomagnetic Micro-Aperture Chip System
- Immunomagnetic Micro-Aperture Chip System Product Overview
- miRNA Based Sequencing Test - Colon Cancer
- miRNA Based Sequencing Test - Colon Cancer Product Overview
- miRNA Based Sequencing Test - Esophageal Cancer
- miRNA Based Sequencing Test - Esophageal Cancer Product Overview
- miRNA Based Sequencing Test - Lung Cancer
- miRNA Based Sequencing Test - Lung Cancer Product Overview
- miRNA Based Sequencing Test - Pancreatic Cancer
- miRNA Based Sequencing Test - Pancreatic Cancer Product Overview
- Signature CF Expand
- Signature CF Expand Product Overview
- Asuragen Inc - Key Competitors
- Asuragen Inc - Key Employees
- Asuragen Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Asuragen Inc, Recent Developments
- Oct 31, 2022: Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference
- Nov 08, 2021: Asuragen launches new kit to enable broader coverage of gene variants linked to cystic fibrosis
- May 10, 2021: Multisite study demonstrates utility of Asuragen kit for identifying variants linked to spinal muscular atrophy
- Nov 10, 2020: Asuragen to present at Association for Molecular Pathology (AMP) 2020 Annual Meeting
- Jul 07, 2020: Asuragen announces CE Mark of AmplideX SMA Plus Kit
- Jun 02, 2020: Asuragen to present at 2020 European Society of Human Genetics (ESHG) Virtual Conference
- Mar 16, 2020: Asuragen develops RNA Quant technology for coronavirus assays
- Feb 24, 2020: FDA grants marketing authorisation for Fragile X Syndrome test
- Nov 26, 2019: Asuragen and Wave Life Sciences to create diagnostics for Huntington's
- Nov 06, 2019: Asuragen announces launch of AmplideX PCR/CE SMN1/2 Plus Kit
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
- Asuragen Inc Pipeline Products by Equipment Type
- Asuragen Inc Pipeline Products by Indication
- Asuragen Inc, Key Facts
- Asuragen Inc, Major Products and Services
- Asuragen Inc Number of Pipeline Products by Development Stage
- Asuragen Inc Pipeline Products Summary by Development Stage
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy - Product Status
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy - Product Description
- Companion Diagnostic Test - Huntington's Disease - Product Status
- Companion Diagnostic Test - Huntington's Disease - Product Description
- Immunomagnetic Micro-Aperture Chip System - Product Status
- Immunomagnetic Micro-Aperture Chip System - Product Description
- miRNA Based Sequencing Test - Colon Cancer - Product Status
- miRNA Based Sequencing Test - Colon Cancer - Product Description
- miRNA Based Sequencing Test - Esophageal Cancer - Product Status
- miRNA Based Sequencing Test - Esophageal Cancer - Product Description
- miRNA Based Sequencing Test - Lung Cancer - Product Status
- miRNA Based Sequencing Test - Lung Cancer - Product Description
- miRNA Based Sequencing Test - Pancreatic Cancer - Product Status
- miRNA Based Sequencing Test - Pancreatic Cancer - Product Description
- Signature CF Expand - Product Status
- Signature CF Expand - Product Description
- Asuragen Inc, Key Employees
- Glossary
- Asuragen Inc Pipeline Products by Equipment Type
- Asuragen Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aviva Systems Biology Corp
- Abazyme LLC
- Verax Biomedical Inc
